bibliographic entry 3058659 [be/3058659]
https://w3id.org/oc/corpus/be/3058659

is a
content
  • Zinman, B. Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME), Cardiovasc Diabetol, 2014, 13, 102, DOI: 10.1186/1475-2840-13-102, PMID: 24943000
references